Quantitative assessment of the in-vitro binding kinetics of antisickling aromatic aldehydes with hemoglobin A: A universal HPLC-UV/Vis method to quantitate Schiff-base adduct formation
Xiaomeng Xu(Virginia Commonwealth University), Jürgen Venitz(National Cancer Institute), Mohini S. Ghatge(Children's Hospital of Philadelphia), Osheiza Abdulmalik(Children's Hospital of Philadelphia), B. Daniel Pierce(Children's Hospital of Philadelphia), Yan Zhang(Virginia Commonwealth University), Ahmed Abdullah Alghamdi(Virginia Commonwealth University), Boshi Huang(Virginia Commonwealth University), Huiqun Wang(Guiyang Medical University), Martin K. Safo(Virginia Commonwealth University)
Cited by 3
Related Papers
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
2‐Methoxyestradiol, a Promising Anticancer Agent
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2003|276
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244
Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia
|Nature Communications|2016|212
G Protein–Coupled Receptor Deorphanizations
|The Annual Review of Pharmacology and Toxicology|2011|193